![]() |
市場調查報告書
商品編碼
1660977
過敏免疫療法市場報告,按治療類型(皮下免疫療法、舌下免疫療法)、過敏類型、配銷通路和地區分類,2025 年至 2033 年Allergy Immunotherapies Market Report by Treatment Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy ), Allergy Type, Distribution Channel, and Region 2025-2033 |
2024IMARC Group全球過敏免疫療法市場規模達到 34 億美元。推動市場發展的因素包括過敏症盛行率不斷上升、人們對免疫療法作為過敏症有效治療方法的認知不斷提高、免疫療法治療和技術的重大發展、政府對過敏研究的優惠政策和資金支持、以及定製藥物和個人化治療方法。
過敏免疫療法,也稱為減敏或低敏療法,是針對對各種食物、藥物、蜂毒、草花粉和屋塵蟎等過敏原的過敏反應的預防性醫療方法。它透過逐漸增加過敏原的劑量來改變免疫系統的反應。在治療開始之前,過敏症專家和患者會分析過敏症狀的誘發因素,這可能涉及皮膚和血液檢查以確認過敏原。過敏免疫療法有助於減少發炎、提供長期影響、增強免疫耐受性、改變疾病進程並改善患者的生活品質。
近年來,由於各種環境和生活方式因素影響了免疫系統的功能,世界各地過敏症的盛行率上升。隨著人們對過敏免疫療法認知的不斷提高、收入水平的提高和醫療保健支出的增加,對複雜和長期治療方案的需求正在增加,這反過來又刺激了市場的成長。由於世界各國政府和非政府組織採取了多項舉措,臨床研究和開發預算的不斷增加進一步支持了這項進程。此外,利用最新的藥物開發技術,製藥公司已經創造出更有效的免疫療法,可成功治療多種過敏。這一趨勢加上過敏診斷領域的進步,正在催化全球過敏免疫療法市場的成長。
The global allergy immunotherapies market size reached USD 3.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.5 Billion by 2033, exhibiting a growth rate (CAGR) of 8.29% during 2025-2033. The market is propelled by the rising prevalence of allergic conditions, increasing awareness about immunotherapy as an effective treatment for allergies, significant developments in immunotherapy treatments and technologies, favorable government policies and funding for allergy research, and customized medicine and tailored treatment approaches.
Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system's response by gradually increasing the doses of the allergen. Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient's life.
In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world. Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth.
The report has also analysed the competitive landscape of the market with some of the key players being ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Holding B.V., DBV Technologies, Merck KGaA, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, and Biomay AG, etc.